168 related articles for article (PubMed ID: 34253709)
21. Identification of DOT1L inhibitor in a screen for factors that promote dopaminergic neuron survival.
Cui J; Carey J; Reijo Pera RA
Front Aging Neurosci; 2022; 14():1026468. PubMed ID: 36578445
[TBL] [Abstract][Full Text] [Related]
22. Histone methyltransferase Dot1L is a coactivator for thyroid hormone receptor during
Wen L; Fu L; Shi YB
FASEB J; 2017 Nov; 31(11):4821-4831. PubMed ID: 28739643
[TBL] [Abstract][Full Text] [Related]
23. Serine hydroxymethyl transferase 1 stimulates pro-oncogenic cytokine expression through sialic acid to promote ovarian cancer tumor growth and progression.
Gupta R; Yang Q; Dogra SK; Wajapeyee N
Oncogene; 2017 Jul; 36(28):4014-4024. PubMed ID: 28288142
[TBL] [Abstract][Full Text] [Related]
24. The Histone Methyltransferase DOT1L Is Essential for Humoral Immune Responses.
Kealy L; Di Pietro A; Hailes L; Scheer S; Dalit L; Groom JR; Zaph C; Good-Jacobson KL
Cell Rep; 2020 Dec; 33(11):108504. PubMed ID: 33326791
[TBL] [Abstract][Full Text] [Related]
25. Computer-Aided Discovery of Massonianoside B as a Novel Selective DOT1L Inhibitor.
Chen J; Park HJ
ACS Chem Biol; 2019 May; 14(5):873-881. PubMed ID: 30951287
[TBL] [Abstract][Full Text] [Related]
26. miR-133b suppresses colorectal cancer cell stemness and chemoresistance by targeting methyltransferase DOT1L.
Lv L; Li Q; Chen S; Zhang X; Tao X; Tang X; Wang S; Che G; Yu Y; He L
Exp Cell Res; 2019 Dec; 385(1):111597. PubMed ID: 31525340
[TBL] [Abstract][Full Text] [Related]
27. Antiproliferative and Antimigration Activities of Fluoro-Neplanocin A via Inhibition of Histone H3 Methylation in Triple-Negative Breast Cancer.
Byun WS; Kim WK; Yoon JS; Jarhad DB; Jeong LS; Lee SK
Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32244385
[TBL] [Abstract][Full Text] [Related]
28. CBP mediated DOT1L acetylation confers DOT1L stability and promotes cancer metastasis.
Liu C; Yang Q; Zhu Q; Lu X; Li M; Hou T; Li Z; Tang M; Li Y; Wang H; Yang Y; Wang H; Zhao Y; Wen H; Liu X; Mao Z; Zhu WG
Theranostics; 2020; 10(4):1758-1776. PubMed ID: 32042335
[No Abstract] [Full Text] [Related]
29. Identification of DOT1L inhibitors by structure-based virtual screening adapted from a nucleoside-focused library.
Gibbons GS; Chakraborty A; Grigsby SM; Umeano AC; Liao C; Moukha-Chafiq O; Pathak V; Mathew B; Lee YT; Dou Y; Schürer SC; Reynolds RC; Snowden TS; Nikolovska-Coleska Z
Eur J Med Chem; 2020 Mar; 189():112023. PubMed ID: 31978781
[TBL] [Abstract][Full Text] [Related]
30. DOT1L inhibitor improves early development of porcine somatic cell nuclear transfer embryos.
Tao J; Zhang Y; Zuo X; Hong R; Li H; Liu X; Huang W; Cao Z; Zhang Y
PLoS One; 2017; 12(6):e0179436. PubMed ID: 28632762
[TBL] [Abstract][Full Text] [Related]
31. DOT1L histone methyltransferase regulates the expression of BCAT1 and is involved in sphere formation and cell migration of breast cancer cell lines.
Oktyabri D; Ishimura A; Tange S; Terashima M; Suzuki T
Biochimie; 2016 Apr; 123():20-31. PubMed ID: 26783998
[TBL] [Abstract][Full Text] [Related]
32. The histone methyltransferase DOT1L: regulatory functions and a cancer therapy target.
Wong M; Polly P; Liu T
Am J Cancer Res; 2015; 5(9):2823-37. PubMed ID: 26609488
[TBL] [Abstract][Full Text] [Related]
33. Regulation of Wnt signaling target gene expression by the histone methyltransferase DOT1L.
Gibbons GS; Owens SR; Fearon ER; Nikolovska-Coleska Z
ACS Chem Biol; 2015 Jan; 10(1):109-14. PubMed ID: 25361163
[TBL] [Abstract][Full Text] [Related]
34. Copy-number variation and protein expression of DOT1L in pancreatic adenocarcinoma as a potential drug target.
Loeser H; Waldschmidt D; Kuetting F; Heydt C; Zander T; Plum P; Alakus H; Buettner R; Quaas A
Mol Clin Oncol; 2017 May; 6(5):639-642. PubMed ID: 28529740
[TBL] [Abstract][Full Text] [Related]
35. Optimization of a Fragment-Based Screening Hit toward Potent DOT1L Inhibitors Interacting in an Induced Binding Pocket.
Scheufler C; Möbitz H; Gaul C; Ragot C; Be C; Fernández C; Beyer KS; Tiedt R; Stauffer F
ACS Med Chem Lett; 2016 Aug; 7(8):730-4. PubMed ID: 27563394
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of Histone Methyltransferase, DOT1L, by Matrix Hyaluronan Promotes MicroRNA-10 Expression Leading to Tumor Cell Invasion and Chemoresistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma.
Bourguignon LY; Wong G; Shiina M
J Biol Chem; 2016 May; 291(20):10571-85. PubMed ID: 27002147
[TBL] [Abstract][Full Text] [Related]
37. Targeting DOT1L and HOX gene expression in MLL-rearranged leukemia and beyond.
Chen CW; Armstrong SA
Exp Hematol; 2015 Aug; 43(8):673-84. PubMed ID: 26118503
[TBL] [Abstract][Full Text] [Related]
38. Discovery of potent DOT1L inhibitors by AlphaLISA based High Throughput Screening assay.
Song Y; Li L; Chen Y; Liu J; Xiao S; Lian F; Zhang N; Ding H; Zhang Y; Chen K; Jiang H; Zhang C; Liu YC; Chen S; Luo C
Bioorg Med Chem; 2018 May; 26(8):1751-1758. PubMed ID: 29534934
[TBL] [Abstract][Full Text] [Related]
39. The histone methyltransferase DOT1L inhibits osteoclastogenesis and protects against osteoporosis.
Gao Y; Ge W
Cell Death Dis; 2018 Jan; 9(2):33. PubMed ID: 29348610
[TBL] [Abstract][Full Text] [Related]
40. Identification of Novel Disruptor of Telomeric Silencing 1-like (DOT1L) Inhibitors through Structure-Based Virtual Screening and Biological Assays.
Chen S; Li L; Chen Y; Hu J; Liu J; Liu YC; Liu R; Zhang Y; Meng F; Zhu K; Lu J; Zheng M; Chen K; Zhang J; Jiang H; Yao Z; Luo C
J Chem Inf Model; 2016 Mar; 56(3):527-34. PubMed ID: 26914852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
